Summary
Quest Diagnostics Incorporated (DGX) has filed an 8-K report detailing the approval of its Executive Officer Severance Plan by the Compensation Committee of its Board of Directors on May 3, 2006. This plan provides significant severance benefits to named executive officers in the event of termination under specific circumstances, particularly following a change in control. The plan outlines detailed definitions for 'Change in Control,' 'Good Reason,' and 'Cause,' setting clear parameters for eligibility for these enhanced benefits.
Key Highlights
- 1Quest Diagnostics established an Executive Officer Severance Plan on May 3, 2006.
- 2The plan provides severance packages for specific executive officers upon termination.
- 3Severance multiples are higher (3x salary and variable compensation) if termination occurs within 24 months after a change in control.
- 4Benefits also include extended medical and life insurance coverage, outplacement services, and 401(k) matching contributions.
- 5The plan defines 'Change in Control' based on stock acquisition thresholds, mergers, board composition changes, or asset sales.
- 6Definitions for 'Good Reason' and 'Cause' are provided, outlining conditions for voluntary termination or termination by the company.
- 7Payments are contingent upon the executive officer executing a release.
Frequently Asked Questions
The primary purpose of the plan is to provide financial security and benefits to key executive officers in the event of termination of employment under specific circumstances, especially in the context of a change in control, to ensure leadership stability and alignment with shareholder interests during potential transition periods.
The higher severance benefits, including three times base salary and variable compensation, are triggered if an executive officer's employment is terminated by the company (other than for cause) or by the executive officer for 'Good Reason' within a 24-month period following a 'Change in Control,' or under certain conditions in anticipation of a change in control.
'Change in Control' is defined broadly and includes events such as a person acquiring 40% or more of the company's voting stock, a merger or similar transaction where Quest Diagnostics' shareholders do not retain majority control, a change in the board of directors composition where incumbent directors are no longer a majority, or shareholder approval of a complete liquidation or sale of substantially all assets.
Yes, severance payments are conditioned on the executive officer executing a release. Furthermore, the plan clearly defines 'Cause' for termination, which would likely exclude severance eligibility if termination is due to an executive's own misconduct or willful failure to perform duties.